新生儿与儿童万古霉素群体药动学模型的系统综述与基于评分的精准给药模型选择
该系统综述检索5个数据库共7915篇文献,纳入112个新生儿与儿童万古霉素群体药动学模型,汇总协变量测试与保留情况,并提出基于人群匹配、模型评价、队列规模与采样方案的选择标准。应用该标准后,Chen(2023)模型在新生儿和儿童人群中评分均最高,可为模型引导精准给药(MIPD)的模型选择提供标准化参考。
要点
- 共纳入112个万古霉素popPK模型,体重是最常测试且保留的协变量(101/106,95.3%)。
- 模型选择应综合人群匹配、内外部评价、队列规模与PK采样方案。
- Chen(2023)模型在新生儿和儿童人群中评分均最高,可优先考虑用于MIPD。
核心结论
- 系统综述识别了112个新生儿与儿童万古霉素popPK模型,并提出了可用于MIPD的模型选择评分标准。
- Chen(2023)模型在新生儿和儿科人群中评分均最高。
研究设计与样本
- 遵循PRISMA指南的系统文献检索(2025年12月;PubMed、EMBASE、WoS、Scopus、IPA),概念为「neonates/children」「vancomycin」「popPK model」。
- 纳入标准为年龄0-18岁、静脉万古霉素、popPK模型开发;共从7915篇文章中识别112个模型(1994-2025年)。
- 模型分布:35个新生儿、6个婴儿、39个儿童、2个青少年、30个混合年龄模型。
- 模型结构:81个一室模型、30个二室模型。
主要发现
- 跨模型共测试180个协变量,保留47个(26.1%)。
- 体重是最常测试且保留的协变量(101/106,95.3%)。
关键数值与推荐
- 模型选择标准包括人群匹配、外部与内部模型评价(校准、区分度、不确定性)、队列规模和PK采样方案。
- 应用选择标准后,Chen(2023)模型在新生儿和儿科人群中评分均最高。
临床怎么用
- 本综述与模型选择工具可指导和标准化MIPD中的popPK模型选择。
- 临床选择新生儿或儿童万古霉素popPK模型时,可参考人群匹配、模型评价、队列规模与采样方案等维度进行评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vancomycin is frequently used to treat gram-positive infections in neonates and children. The optimal marker for efficacy and toxicity is the 24-h area under the concentration-time curve/minimal inhibitory concentration, which can be estimated using population pharmacokinetic (popPK) models. These models can be integrated into model-informed precision dosing (MIPD) tools to personalize therapy. This study aimed to systematically review neonatal and paediatric vancomycin popPK models and develop a model selection tool for MIPD. A systematic literature search (December 2025; PubMed, EMBASE, WoS, Scopus, IPA) was conducted following PRISMA guidelines using the concepts 'neonates/children', 'vancomycin' and 'popPK model'. Inclusion criteria were age 0-18 years, intravenous vancomycin, and popPK model development. Descriptive statistics summarized tested vs. retained covariates. Based on literature and multidisciplinary expert input, model selection criteria were proposed and applied to the identified models. Across 7915 articles, 112 popPK models were identified (1994-2025; 35 neonatal, 6 infantile, 39 paediatric, 2 adolescent, 30 mixed-age). Models were built on data from median (range) 114 (6-7167) patients, representing 337 (26-13 372) PK samples. There were 81 one- and 30 two-compartment models. Of 180 covariates tested across models, 47 (26.1%) were retained. Body weight was most frequently tested and retained (101/106, 95.3%). Model selection criteria included matching population, external and internal model evaluation (calibration, discrimination, uncertainty), cohort size, PK sampling schedule. The Chen (2023) model scored highest for both the neonatal and paediatric populations. This review and model selection tool can guide and standardize model selection for MIPD.
引用
- Vander Elst Z, Spiessens PJ, Vanneste D, et al. Systematic review and scoring-based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children. Br J Clin Pharmacol. 2026. PMID: 41873632. doi:10.1002/bcp.70530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。